Ultragenyx Pharmaceutical (RARE) Operating Income (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.18% |
| Dec 31, 2025 | 33.71% |
| Sep 30, 2025 | -58.40% |
| Jun 30, 2025 | 24.55% |
| Mar 31, 2025 | -16.92% |
| Dec 31, 2024 | 7.34% |
| Sep 30, 2024 | -13.43% |
| Jun 30, 2024 | 29.63% |
| Mar 31, 2024 | -35.71% |
| Dec 31, 2023 | 16.03% |
| Sep 30, 2023 | 1.93% |
| Jun 30, 2023 | 3.99% |
| Mar 31, 2023 | -5.82% |
| Dec 31, 2022 | 35.30% |
| Sep 30, 2022 | -58.95% |
| Jun 30, 2022 | -3.63% |
| Mar 31, 2022 | -33.22% |
| Dec 31, 2021 | -14.18% |
| Sep 30, 2021 | -8.52% |
| Jun 30, 2021 | 22.33% |
| Mar 31, 2021 | -10.92% |
| Dec 31, 2020 | -90.96% |
| Sep 30, 2020 | 20.20% |
| Jun 30, 2020 | 47.74% |
| Mar 31, 2020 | -27.75% |
| Dec 31, 2019 | 19.98% |
| Sep 30, 2019 | -4.94% |
| Jun 30, 2019 | -13.37% |
| Mar 31, 2019 | -9.82% |
| Dec 31, 2018 | -0.77% |
| Sep 30, 2018 | 5.54% |
| Jun 30, 2018 | 1.64% |
| Mar 31, 2018 | 0.36% |
| Dec 31, 2017 | -15.67% |
| Sep 30, 2017 | -6.72% |
| Jun 30, 2017 | -12.13% |
| Mar 31, 2017 | 0.84% |
| Dec 31, 2016 | -7.25% |
| Sep 30, 2016 | -13.32% |
| Jun 30, 2016 | -8.26% |
| Mar 31, 2016 | 4.52% |
| Dec 31, 2015 | -40.62% |
| Sep 30, 2015 | -32.49% |
| Jun 30, 2015 | -40.18% |
| Mar 31, 2015 | -26.91% |
| Dec 31, 2014 | -7.00% |
| Sep 30, 2014 | -15.91% |
| Jun 30, 2014 | -32.13% |
| Mar 31, 2014 | -8.55% |
| Dec 31, 2013 | -22.73% |
| Sep 30, 2013 | 5.89% |
| Jun 30, 2013 | -22.23% |